World Smallpox Treatment Market Report 2023-2030: Antiviral Drugs, Vaccination, Supportive Care Size, Share, Outlook, and Opportunity Analysis
02 oct. 2023 04h50 HE
|
Research and Markets
Dublin, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The "Smallpox Treatment Market, By Treatment Type, By Product Type, By Distribution Channel, By End User, And By Region - Size, Share, Outlook, and...
Rise in Viral Infections Drives Growth in the Oral Antiviral Market: 2021-2031 Forecast
21 sept. 2023 06h59 HE
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- ResearchAndMarkets.com announces a comprehensive analysis of the Oral Antiviral Market, projecting a promising CAGR of 2.1% from 2022 to 2031. The "Oral...
Defending against Viral Threats: Global Antiviral Drugs Market to Reach $74.75 Billion by 2028
04 sept. 2023 09h36 HE
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Antiviral Drugs Market (2023-2028) by Drug Type, Disease, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report...
Defending against Viral Threats: Global Antiviral Drugs Market to Reach $74.75 Billion by 2028
04 sept. 2023 09h34 HE
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Antiviral Drugs Market (2023-2028) by Drug Type, Disease, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report...
Molnupiravir Global Market Report 2023: Rising Instances of COVID-19 Drives Growth
08 mars 2023 05h03 HE
|
Research and Markets
Dublin, March 08, 2023 (GLOBE NEWSWIRE) -- The "Molnupiravir Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Application (Influenza, Ebola, COVID-19,...
Antivirals Global Market Report 2023: A $156.99 Billion Market by 2027 - Long-term Forecast to 2032 Featuring AbbVie, Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche, & Gilead Sciences
22 févr. 2023 08h03 HE
|
Research and Markets
Dublin, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The "Antivirals Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global antivirals market will grow from $97.14...
Nature Reviews Drug Discovery Article Offers Independent Support for ProLectin-I in Fibrosis and ProLectin-M as an Antiviral Drug
22 févr. 2023 08h00 HE
|
BIOXYTRAN, INC.
BOSTON, MASSACHUSETTS, Feb. 22, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat...
Crystal Research Update Highlights 100% Responders Rate in Mild to Moderate COVID-19 Trial
28 déc. 2022 07h00 HE
|
BIOXYTRAN, INC.
Trial meets endpoints in safety and efficacyIND Letter from the CDSCO to optimize dosageEstablishment of an Indian Subsidiary to commercialize ProLectin-M BOSTON, MASSACHUSETTS, Dec. 28,...
Bioxytran Establishes Indian Subsidiary in Preparation of Commercialization
14 déc. 2022 07h00 HE
|
BIOXYTRAN, INC.
BOSTON, MASSACHUSETTS, Dec. 14, 2022 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19...
Antiviral Drugs Global Market Report 2022: COVID-19 Spurred Several Players to Begin Developing Novel Antiviral Therapies with Multiple Applications
24 nov. 2022 04h13 HE
|
Research and Markets
Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The "Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global...